Baidu
map

中南大学校长谈科研:一个学院办几十个公司,还能搞好科研吗

2016-07-26 佚名 不详

5月30日,我参加了全国科技创新大会,聆听了习近平总书记所作的激动人心的报告。习近平总书记指出,实现“两个一百年”奋斗目标,实现中华民族伟大复兴的中国梦,必须坚持走中国特色自主创新道路,面向世界科技前沿、面向经济主战场、面向国家重大需求,加快各领域科技创新,掌握全球科技竞争先机。

写论文的目的,本应是为了和同行交流科研成果,但现在的考评机制,把论文篇数和刊物级别、影响因子看得过重,把一些年轻人才和科学家都影响坏了。

习近平总书记还强调,历史经验表明,科技革命总是能够深刻改变世界发展格局。的确,如果我们有高科技,鸦片战争中我们会输吗?如果伊拉克掌握了信息技术,海湾战争中美国能以那么小的代价那么迅速地打赢战争吗?大学也是一样,如果没有拿得出手的科技成果,没有产生与众不同的、独一无二的、立得住脚的思想与理论,总是跟着别人,这所大学谈何一流?

在习近平总书记重要讲话精神指导下,如何搞好大学里的科研工作?我认为重点要抓好三个回归,即回归兴趣、回归学术和回归需求,也就是把学术导向、问题导向和个人的兴趣爱好紧密结合起来。

凑数的论文,就是一种科研浪费

长期以来,论文问题一直困扰着大学里的科研人员。年复一年,大家都会写很多论文,但其中很大一部分就是为了凑篇数、提职称。写论文的目的,本应是为了和同行交流科研成果,但现在的考评机制,把论文篇数和刊物级别、影响因子看得过重,把一些年轻人才和科学家都影响坏了。不在圈子里发表不了,不引用“大牛”的文章发表不了,不是热点问题发表不了。近些年,国内的论文数量的确增加不少,但这些论文对推动经济转型发展,对解决国家发展面临的实际问题的贡献有多少呢?现在已经到了必须进行反思的时候了。

这几年,中南大学的论文数量也在不断增加。我们进入ESI全球前1%的学科数从4个增加到10个。但是我们发表的这些论文中,有几篇能够在历史上留下印迹?又有多少原创的理论和成果?

搞科研,并不是不需要重视论文,只是不要唯论文而论文。那些凑数的论文,实际上是科研资源与科研时间的浪费。所以,在追求论文数量的同时,必须把质量放在第一位,要把学术研究和解决中国的实际问题放在第一位。今后的人才评价工作,特别是评职称的时候,应把代表作和现实贡献结合起来评价,不能只看论文篇数。

一个学院办几十个公司,还能搞好科研吗

大学科研工作要搞好,科研人员必须先收心,老师们不要再在公司兼职和办企业。以前,大家办企业或兼职,确实对推动科技成果产业化起了积极作用。但大家也要高度认识到其对科技事业带来的负面作用。我们几个主干学院的理论研究水平为什么老上不去?与我们的教师在成果转化上投入太多,但在新成果研发上投入太少有无关系?搞企业绝对不是教授的长项,否则还要企业家干什么?今后的成果转化应该以知识产权转移为主。大学教授要收心,要回归学术,要把时间与精力投入学术活动,这才是教授的本行。大家想想,一个学院办几十个公司,还能搞好科研吗?

中南大学每年拿出近2个亿投入科研,我们还在外面争取了不少科研经费。与兄弟院校比,我们的经费不算是少的。但我始终认为,对科研工作来说,最重要的是投入思想。你脑子里不整天想着研究的事,投入再多钱也没用。科研人员的心要收回来,心不收回来,是做不好研究的!从实践中看,全球基础研究领域的重大成果,有几个是用钱堆出来的?相对论的提出花了多少钱?当然,做实验、做工程是要花钱的。但我们不要光想着怎么挣钱,光讲短期效应,这能做出什么成果来?而且,科研并不是投入资金就一定会成功的。科学研究没有中间道路,成了就成了,不成就拉倒,但是需要你扎扎实实坐下来、认认真真作研究。

要在年轻力壮时,把“武功”练成

搞好科研工作,最重要的还是人才队伍建设。但大学人才队伍建设不能光看教授和海归的数量,更应关注的是,我们的教授在各自专业领域在全国说话有地位的有几个?

教师们要安心做学问,但是做学问不是不跟外界联系。学校要努力培养安心做科研的年轻人,但年轻人也要努力走出去,要看看自己作为一个学者,跟你学科领域的同行、政府的管理部门、产业部门联系多不多?跟国外同行交流合作有没有?如果都是坐在家里等,不走出去,如何把论文写在中国的大地上?如何拿出在国际上有影响的成果?

我们的人才,特别是年轻人才,必须要回归兴趣、回归学术。人才最具创造力的时间就是在青年时代,诺贝尔奖获得者的得奖成果基本上都是在35岁之前拿出来的。大家要有紧迫感,要在自己年轻力壮时,找到自己科研的兴趣点,用心把“武功”练成。

搞好科研,还必须注意用心凝练方向。这次中南大学花两个月时间开科技与人才工作会,就是要让大家多多提意见,凝练好科研方向。大家要把视野放长远一点,要看到学科在今后10年、20年或者更远时间里的发展趋势,再结合自身的基础条件和优势,看在哪些方面能够做得出有影响的东西来,要把自己的优势,与国家发展建设的需求紧密结合,与民族复兴的远大理想紧密结合。(生物谷 Bioon.com)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=108842, encodeId=f2941088421d, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 12:56:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=107018, encodeId=5dab10e018a4, content=说的挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ab1619415, createdName=lecoo, createdTime=Mon Aug 29 23:14:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105555, encodeId=71dc10555587, content=这篇资讯写的真好,带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 14:17:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=98745, encodeId=01c898e4528, content=从实际出发, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe991935216, createdName=1e0db677m16(暂无匿称), createdTime=Mon Aug 15 06:39:00 CST 2016, time=2016-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741901, encodeId=bc571e41901b4, content=<a href='/topic/show?id=8f996203462' target=_blank style='color:#2F92EE;'>#校长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62034, encryptionId=8f996203462, topicName=校长)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=320934995200, createdName=liao1631, createdTime=Thu Jun 08 01:57:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94843, encodeId=1c09948438c, content=科研要沉下心来研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Jul 27 10:55:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94777, encodeId=a5c494e77ce, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Jul 26 22:02:00 CST 2016, time=2016-07-26, status=1, ipAttribution=)]
    2016-09-01 李东泽

    很好,不错,以后会多学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=108842, encodeId=f2941088421d, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 12:56:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=107018, encodeId=5dab10e018a4, content=说的挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ab1619415, createdName=lecoo, createdTime=Mon Aug 29 23:14:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105555, encodeId=71dc10555587, content=这篇资讯写的真好,带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 14:17:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=98745, encodeId=01c898e4528, content=从实际出发, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe991935216, createdName=1e0db677m16(暂无匿称), createdTime=Mon Aug 15 06:39:00 CST 2016, time=2016-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741901, encodeId=bc571e41901b4, content=<a href='/topic/show?id=8f996203462' target=_blank style='color:#2F92EE;'>#校长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62034, encryptionId=8f996203462, topicName=校长)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=320934995200, createdName=liao1631, createdTime=Thu Jun 08 01:57:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94843, encodeId=1c09948438c, content=科研要沉下心来研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Jul 27 10:55:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94777, encodeId=a5c494e77ce, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Jul 26 22:02:00 CST 2016, time=2016-07-26, status=1, ipAttribution=)]
    2016-08-29 lecoo

    说的挺好的

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=108842, encodeId=f2941088421d, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 12:56:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=107018, encodeId=5dab10e018a4, content=说的挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ab1619415, createdName=lecoo, createdTime=Mon Aug 29 23:14:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105555, encodeId=71dc10555587, content=这篇资讯写的真好,带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 14:17:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=98745, encodeId=01c898e4528, content=从实际出发, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe991935216, createdName=1e0db677m16(暂无匿称), createdTime=Mon Aug 15 06:39:00 CST 2016, time=2016-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741901, encodeId=bc571e41901b4, content=<a href='/topic/show?id=8f996203462' target=_blank style='color:#2F92EE;'>#校长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62034, encryptionId=8f996203462, topicName=校长)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=320934995200, createdName=liao1631, createdTime=Thu Jun 08 01:57:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94843, encodeId=1c09948438c, content=科研要沉下心来研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Jul 27 10:55:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94777, encodeId=a5c494e77ce, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Jul 26 22:02:00 CST 2016, time=2016-07-26, status=1, ipAttribution=)]
    2016-08-27 李东泽

    这篇资讯写的真好,带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=108842, encodeId=f2941088421d, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 12:56:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=107018, encodeId=5dab10e018a4, content=说的挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ab1619415, createdName=lecoo, createdTime=Mon Aug 29 23:14:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105555, encodeId=71dc10555587, content=这篇资讯写的真好,带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 14:17:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=98745, encodeId=01c898e4528, content=从实际出发, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe991935216, createdName=1e0db677m16(暂无匿称), createdTime=Mon Aug 15 06:39:00 CST 2016, time=2016-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741901, encodeId=bc571e41901b4, content=<a href='/topic/show?id=8f996203462' target=_blank style='color:#2F92EE;'>#校长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62034, encryptionId=8f996203462, topicName=校长)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=320934995200, createdName=liao1631, createdTime=Thu Jun 08 01:57:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94843, encodeId=1c09948438c, content=科研要沉下心来研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Jul 27 10:55:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94777, encodeId=a5c494e77ce, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Jul 26 22:02:00 CST 2016, time=2016-07-26, status=1, ipAttribution=)]
    2016-08-15 1e0db677m16(暂无匿称)

    从实际出发

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=108842, encodeId=f2941088421d, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 12:56:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=107018, encodeId=5dab10e018a4, content=说的挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ab1619415, createdName=lecoo, createdTime=Mon Aug 29 23:14:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105555, encodeId=71dc10555587, content=这篇资讯写的真好,带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 14:17:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=98745, encodeId=01c898e4528, content=从实际出发, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe991935216, createdName=1e0db677m16(暂无匿称), createdTime=Mon Aug 15 06:39:00 CST 2016, time=2016-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741901, encodeId=bc571e41901b4, content=<a href='/topic/show?id=8f996203462' target=_blank style='color:#2F92EE;'>#校长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62034, encryptionId=8f996203462, topicName=校长)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=320934995200, createdName=liao1631, createdTime=Thu Jun 08 01:57:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94843, encodeId=1c09948438c, content=科研要沉下心来研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Jul 27 10:55:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94777, encodeId=a5c494e77ce, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Jul 26 22:02:00 CST 2016, time=2016-07-26, status=1, ipAttribution=)]
    2017-06-08 liao1631
  6. [GetPortalCommentsPageByObjectIdResponse(id=108842, encodeId=f2941088421d, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 12:56:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=107018, encodeId=5dab10e018a4, content=说的挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ab1619415, createdName=lecoo, createdTime=Mon Aug 29 23:14:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105555, encodeId=71dc10555587, content=这篇资讯写的真好,带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 14:17:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=98745, encodeId=01c898e4528, content=从实际出发, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe991935216, createdName=1e0db677m16(暂无匿称), createdTime=Mon Aug 15 06:39:00 CST 2016, time=2016-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741901, encodeId=bc571e41901b4, content=<a href='/topic/show?id=8f996203462' target=_blank style='color:#2F92EE;'>#校长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62034, encryptionId=8f996203462, topicName=校长)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=320934995200, createdName=liao1631, createdTime=Thu Jun 08 01:57:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94843, encodeId=1c09948438c, content=科研要沉下心来研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Jul 27 10:55:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94777, encodeId=a5c494e77ce, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Jul 26 22:02:00 CST 2016, time=2016-07-26, status=1, ipAttribution=)]
    2016-07-27 明崖

    科研要沉下心来研究

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=108842, encodeId=f2941088421d, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Sep 01 12:56:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=107018, encodeId=5dab10e018a4, content=说的挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ab1619415, createdName=lecoo, createdTime=Mon Aug 29 23:14:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105555, encodeId=71dc10555587, content=这篇资讯写的真好,带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 14:17:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=98745, encodeId=01c898e4528, content=从实际出发, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe991935216, createdName=1e0db677m16(暂无匿称), createdTime=Mon Aug 15 06:39:00 CST 2016, time=2016-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741901, encodeId=bc571e41901b4, content=<a href='/topic/show?id=8f996203462' target=_blank style='color:#2F92EE;'>#校长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62034, encryptionId=8f996203462, topicName=校长)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=320934995200, createdName=liao1631, createdTime=Thu Jun 08 01:57:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94843, encodeId=1c09948438c, content=科研要沉下心来研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Jul 27 10:55:00 CST 2016, time=2016-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94777, encodeId=a5c494e77ce, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Jul 26 22:02:00 CST 2016, time=2016-07-26, status=1, ipAttribution=)]
    2016-07-26 1dd8c52fm63(暂无匿称)

    继续关注!

    0

相关资讯

ASCO 2016:简单的血液测试与组织活检一样有效地监控癌症

一项新的研究表明血液样品测试能够与侵入性组织活检一样有效地监控癌症,并且能够有助医生更好地开药治疗。根据在2016年美国临床肿瘤学会(American Society of Clinical Oncology, ASCO)年度会议上发布的这项研究,尽管肿瘤活检通常被用来评估癌症DNA发生的变化,但是血液样品测试也能够做同样的事情。根据研究人员的说法,新的研究进展允许人们以血液为对象研究癌症,这

罗氏:FDA批准非小细胞肺癌(NSCLC)血液样本基因检测试剂盒

瑞士制药巨头罗氏(Roche)近日宣布,美国食品和药物管理局(FDA)已批准cobas EGFR Mutation Test v2(cobas EGFR突变检测试剂盒v2),这是一款以血液为基础的、用于抗癌药特罗凯(Tarceva,通用名:erlotinib,厄洛替尼)的伴随诊断试剂盒。值得一提的是,这是FDA批准的首个以血液为基础、用于检测非小细胞肺癌(NSCLC)患者表皮生长因子受体(EGF

Hepatology:新方法允许一步法诊断HCV感染

当前诊断丙型肝炎病毒(HCV)感染的标准方法需要两个连续的步骤:用于筛选的HCV抗体测试,随后进行HCV RNA RT-PCR测试来验证病毒血症性HCV(viremic HCV, V-HCV)感染(编者注:即导致病毒血症的HCV感染)。这使得它未最优化、成本高、不方便、耗时和不能够在全球广泛使用或负担得起。HCV核心抗原(HCVcAg)测试有潜力提供一步法诊断HCV感染。然而,它的灵敏度和特异

穿着仅供研究外衣 过敏原诊断试剂无证上岗

穿着仅供研究外衣 过敏原诊断试剂无证上岗 中国青年报记者调查发现,北京、上海、南京等地的多家知名医院、研究所,近年来曾将本应“仅供研究”的未经注册医疗器械,用于临床诊断。 这些医疗器械,均为著名外企赛默飞世尔科技(中国)有限公司(以下简称“赛默飞公司”)Phadia过敏原诊断试剂中的一部分产品。该产品属于按医疗器械管理的体外诊断试剂,且为风险程度最高的第三类产品。按照规定,在未获得医疗

参会指南:2016液体活检产业发展论坛

2016液体活检产业发展论坛围绕液体活检的市场、技术、临床应用和未来趋势展开深入探讨,力求使与会者近距离接触液体活检相关企业的先驱和创新公司,了解液体活检市场最真实的需求和着力点,助力研究机构和企业挖掘技术和市场中的亮点和潜伏的机会。 本次会议出席的演讲嘉宾有 潘柏申 施奇惠 汉雨生 田埂 何伟 王立华 许明炎 胡欣 张道允 柯尊富 应康 金刚 朱师达 廖玮等十余位业内知名转化和企业领袖,

《医疗器械临床试验质量管理规范》今日实行

为加强医疗器械临床试验监督管理,维护医疗器械临床试验过程中受试者权益,保证医疗器械临床试验过程规范,国家食品药品监督管理总局、国家卫生计生委联合发布的《医疗器械临床试验质量管理规范》今起施行。 规范提出,在受试者参与临床试验前,研究者应当充分向受试者或者无民事行为能力人、限制民事行为能力人的监护人说明临床试验的详细情况,包括已知的、可以预见的风险和可能发生的不良事件等。申办者对发生与试验相关

Baidu
map
Baidu
map
Baidu
map